TheraRadar
Clinical-Stage Companies / SK Chemicals

SK Chemicals

Pre-Approval PRO BETA
🔴

Stale Activity

No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 12/16/2022

41
Total Trials
18
Phase 3
7
Phase 2
0
Recruiting
368
Score

Pipeline by Phase

Phase 3
18
Phase 2
7
Phase 1
14

Therapeutic Focus

Influenza, Human Pneumococcal Infections Healthy Subjects Influenza Herpes Zoster

Clinical Trials (41)

NCT05930080 Phase 3 COMPLETED

Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial

Started: 1/28/2021

NCT02467842 Phase 3 COMPLETED

Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects

Started: 10/1/2014

NCT02927444 Phase 3 COMPLETED

Immunogenicity and Safety Study of NBP606 in Healthy Toddlers

Started: 11/4/2015

NCT02201030 Phase 3 COMPLETED

Immunogenicity and Safety Study of NBP606 in Healthy Infants

Started: 9/6/2014

NCT03318276 Phase 3 COMPLETED

Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease

Started: 2/20/2017

NCT03020628 Phase 3 COMPLETED

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months

Started: 10/1/2016

NCT03120364 Phase 3 COMPLETED

Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Started: 9/9/2015

NCT02485067 Phase 3 COMPLETED

Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB

Started: 1/1/2015

NCT01907763 Phase 3 TERMINATED

Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients

Started: 1/1/2013

NCT02079207 Phase 3 COMPLETED

Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine

Started: 12/1/2013

NCT02621164 Phase 3 COMPLETED

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents

Started: 9/1/2014

NCT02621177 Phase 3 COMPLETED

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents

Started: 11/1/2013

NCT01513850 Phase 3 COMPLETED

A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients

Started: 10/1/2010

NCT02344134 Phase 3 COMPLETED

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects

Started: 9/1/2013

NCT01249196 Phase 3 COMPLETED

A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease

Started: 5/1/2010

NCT00931008 Phase 3 COMPLETED

Study to Evaluate SID 530 Compared to Taxotere

Started: 10/1/2009

NCT01513161 Phase 3 COMPLETED

Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis

Started: 4/1/2008

NCT03116594 Phase 2 COMPLETED

Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Started: 1/3/2014

NCT03114982 Phase 2 COMPLETED

The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age

Started: 5/1/2016

NCT02082457 Phase 2 COMPLETED

Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation

Started: 12/1/2013

NCT02079675 Phase 2 COMPLETED

Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome

Started: 1/1/2013

NCT00936624 Phase 2 COMPLETED

Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma

Started: 7/1/2009

NCT01578811 Phase 2 COMPLETED

Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis

Started: 8/1/2011

NCT05236998 Phase 1 COMPLETED

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Started: 11/3/2021

NCT05453786 Phase 1 COMPLETED

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Started: 6/23/2022

NCT04401137 Phase 1 COMPLETED

The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects

Started: 7/1/2020

NCT03893669 Phase 1 COMPLETED

Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy Adults

Started: 9/1/2012

NCT03826719 Phase 1 COMPLETED

Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers

Started: 2/17/2014

NCT02202408 Phase 1 COMPLETED

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670

Started: 6/1/2014

NCT03121638 Phase 1 COMPLETED

Safety Study of NBP608 in Healthy Adult Volunteers

Started: 11/1/2012

NCT02625714 Phase 1 COMPLETED

Safety/Tolerability and Pharmacokinetic Study of SID142

Started: 6/1/2015

NCT02485041 Phase 1 COMPLETED

Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg

Started: 11/1/2014

NCT02485028 Phase 1 COMPLETED

Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg

Started: 10/1/2013

NCT00626743 Phase 1 COMPLETED

Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine

Started: 5/1/2008

NCT01563432 Phase 1 COMPLETED

Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers

Started: 1/1/2012

NCT01248650 Phase 1 COMPLETED

Safety Study of TRK-820 for Patient With Hemodialysis

Started: 12/1/2008

NCT00846274 Phase 1 COMPLETED

Phase1 Syudy to Evaluate the Safety and PK/PD of Human Antithrombin III

Started: 10/1/2008

NCT05445895 Phase 4 COMPLETED

A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke

Started: 12/16/2022

NCT05906199 Phase 4 COMPLETED

A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy.

Started: 7/28/2021

NCT04821687 Phase 4 COMPLETED

A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD

Started: 6/17/2021

NCT01293955 Phase 4 COMPLETED

Assessment of Protective Effect of JOINS on Cartilage in Knee Osteoarthritis

Started: 8/1/2010

Drug Candidates

Renexin CR 200/160mg Plavix 75mg Aspirin 100mg SKCPT Celebrex Ongentys 50mg Madopar Tab. 125 or Perkin Tab. 25-100mg SID1903 (FDC) Dapagliflozin and Sitagliptin SID1903
Activity Status: Stale
Last Trial Started: 12/16/2022
Last Trial Ended: 11/7/2025
Trials (12 months): 0
Completed Trials: 40
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.